Abstract
Gestational Diabetes Mellitus (GDM) is an important public health problem. Prevalence has shown an increasing trend and varies based on diagnostic criteria used and the ethnic group studied. It is more common in Asia. Presently, there is no international consensus on the screening and diagnostic criteria for GDM. The Diabetes in Pregnancy Study Group of India (DIPSI) guidelines recommend the non-fasting 75g oral glucose tolerance test (OGTT) as a single-step screening and diagnostic test for GDM, is simple, easy and more feasible. The objective of this study was to compare whether the DIPSI criteria is equally sensitive to WHO 2018 criteria. This was a hospital based cross-sectional study done at Nepal Medical College Teaching Hospital, Kathmandu. Among 425 cases, 25 (5.88%) were diagnosed GDM, 6 (1.41%) were diagnosed only by DIPSI, 5 (1.18) only by WHO 2018 and 14 (3.29%) by both methods. The study showed that the sensitivity of DIPSI was 73.68% and specificity was 98.52%. The agreement between the DIPSI and WHO 2018 criteria ranged from 60% to 80% (Kappa value = 0.68). This study proves that DIPSI criteria is comparable to WHO 2018 criteria and can be adopted in our institution for the diagnosis of GDM as it is more feasible, easy and less expensive.
Highlights
Gestational Diabetes Mellitus (GDM) is an important public health problem
Prevalence of GDM varied widely based on the diagnostic criteria used[6,7,8] and the ethnic group studied.[9,10,11]
This study showed Diabetes in Pregnancy Study Group of India (DIPSI) criteria is comparable to WHO 2018 criteria
Summary
Gestational Diabetes Mellitus (GDM) is an important public health problem. Women diagnosed to have GDM are at increased risk of future diabetes predominantly type-2 diabetes mellitus (DM) as are their children.[2] It is associated with adverse maternal and perinatal outcome.[3,4]. 18.4 million of these cases were due to GDM.[5] Prevalence of GDM varied widely based on the diagnostic criteria used[6,7,8] and the ethnic group studied.[9,10,11] In a study carried out by Shrestha et al,[12] the prevalence was 4.5% using WHO criteria among pregnant women attending a tertiary hospital in Kathmandu, Nepal
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
